Postępy Dermatologii i Alergologii

Abstract

3/2026 vol. 43
Review paper

Latex allergy and medical aspects of the use of latex products

  1. Individual Specialist Medical Practice, Warsaw, Poland

  2. Clinical Department of Pulmonology, Internal Medicine, Thoracic Oncology and Transplantology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland

Adv Dermatol Allergol 2026; XLIII (3): 209–220

Online publish date: 2026/07/19
View full text

Introduction

Latex allergy remains a significant occupational and clinical challenge in healthcare environments.

Aim

The aim of this review study was to systematically analyse existing scientific data on the allergenic potential of latex, the clinical typology of allergic reactions, diagnostic capabilities, and preventive strategies in the medical environment.

Methods

The review included systematic reviews, clinical and epidemiological studies as well as case reports. All publications appeared in peer-reviewed journals between 2013 and 2025.

Results

The analysis showed that latex allergy is predominantly immunoglobulin E-mediated hypersensitivity to latex proteins (Hevea brasiliensis allergen b 1-15) and chemical compounds used in its production. Hevea brasiliensis allergens b 5 and b 6.02 demonstrate the highest allergenic potency among healthcare workers. In patients with congenital abnormalities, particularly those undergoing multiple surgical procedures, sensitization is more frequently associated with Hevea brasiliensis allergens b 1 and b 3. Sensitization may occur through dermal contact, inhalation exposure, or parenteral routes. Clinical manifestations range from urticaria and rhinitis to anaphylaxis. Diagnosis is based on skin prick tests, specific immunoglobulin E determination, and molecular diagnostics. The frequency of sensitization among healthcare workers reaches 22%, especially with frequent contact with gloves with a high protein content and aerosol latex (up to 9.4 ng/m³). A reliable relationship between the level of exposure and the risk of sensitization has been established (p-trend = 0.03). Prevention includes switching to gloves with reduced protein content, avoiding powdered products, using latex-alternative materials, training staff, and applying latex-free protocols in patients at risk.

Conclusions

The results confirm the need for a comprehensive strategy for the prevention of latex allergy in healthcare settings, with an emphasis on protecting staff health, reducing allergen exposure, and ensuring patient safety.

Share
without publication fees